Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | TTLL3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TTLL3 mRNA | CTD | PMID:32109520 | TTLL3 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TTLL3 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTLL3 mRNA | CTD | PMID:28628672 | TTLL3 | Human | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTLL3 mRNA | CTD | PMID:28628672 | TTLL3 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Ttll3 (Mus musculus) | 6480464 | Fenretinide results in increased expression of TTLL3 mRNA | CTD | PMID:28973697 | TTLL3 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of TTLL3 mRNA | CTD | PMID:25825206 and PMID:30047161 | TTLL3 | Human | acetamide | increases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of TTLL3 mRNA | CTD | PMID:31881176 | TTLL3 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of TTLL3 mRNA | CTD | PMID:33167477 | TTLL3 | Human | all-trans-retinoic acid | multiple interactions | ISO | Ttll3 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TTLL3 mRNA | CTD | PMID:36189433 | TTLL3 | Human | alpha-Zearalanol | multiple interactions | ISO | Ttll3 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TTLL3 mRNA | CTD | PMID:35163327 | TTLL3 | Human | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of TTLL3 mRNA | CTD | PMID:19774075 | TTLL3 | Human | amitrole | decreases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of TTLL3 mRNA | CTD | PMID:30047161 | TTLL3 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of TTLL3 mRNA | CTD | PMID:24449571 | TTLL3 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of TTLL3 mRNA | CTD | PMID:33212167 | TTLL3 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of TTLL3 promoter | CTD | PMID:27901495 | TTLL3 | Human | bisphenol A | decreases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of TTLL3 mRNA | CTD | PMID:25181051 and PMID:32145629 | TTLL3 | Human | bisphenol A | decreases expression | ISO | Ttll3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of TTLL3 mRNA | CTD | PMID:32156529 | TTLL3 | Human | bisphenol A | increases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of TTLL3 mRNA | CTD | PMID:34947998 | TTLL3 | Human | bisphenol A | increases methylation | ISO | Ttll3 (Mus musculus) | 6480464 | bisphenol A results in increased methylation of TTLL3 promoter | CTD | PMID:27312807 | TTLL3 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TTLL3 mRNA | CTD | PMID:28628672 | TTLL3 | Human | bisphenol F | decreases expression | ISO | Ttll3 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of TTLL3 mRNA | CTD | PMID:38685157 | TTLL3 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of TTLL3 mRNA | CTD | PMID:26079696 | TTLL3 | Human | cadmium atom | multiple interactions | ISO | Ttll3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TTLL3 mRNA | CTD | PMID:37325564 | TTLL3 | Human | cadmium dichloride | multiple interactions | ISO | Ttll3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TTLL3 mRNA | CTD | PMID:37325564 | TTLL3 | Human | carbon nanotube | decreases expression | ISO | Ttll3 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | TTLL3 | Human | choline | multiple interactions | ISO | Ttll3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TTLL3 mRNA | CTD | PMID:20938992 | TTLL3 | Human | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of TTLL3 mRNA | CTD | PMID:20971185 | TTLL3 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of TTLL3 mRNA | CTD | PMID:20971185 | TTLL3 | Human | Cuprizon | increases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of TTLL3 mRNA | CTD | PMID:26577399 | TTLL3 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TTLL3 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTLL3 mRNA | CTD | PMID:28628672 | TTLL3 | Human | dibenz[a,h]anthracene | decreases expression | ISO | Ttll3 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | TTLL3 | Human | dimethylarsinic acid | multiple interactions | ISO | Ttll3 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL3 mRNA | CTD | PMID:34876320 | TTLL3 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of TTLL3 mRNA | CTD | PMID:29803840 | TTLL3 | Human | endosulfan | increases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of TTLL3 mRNA | CTD | PMID:29391264 | TTLL3 | Human | folic acid | multiple interactions | ISO | Ttll3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TTLL3 mRNA | CTD | PMID:20938992 | TTLL3 | Human | hypochlorous acid | decreases expression | ISO | Ttll3 (Mus musculus) | 6480464 | Hypochlorous Acid results in decreased expression of TTLL3 mRNA | CTD | PMID:19376150 | TTLL3 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TTLL3 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTLL3 mRNA | CTD | PMID:28628672 | TTLL3 | Human | L-methionine | multiple interactions | ISO | Ttll3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TTLL3 mRNA | CTD | PMID:20938992 | TTLL3 | Human | methimazole | decreases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of TTLL3 mRNA | CTD | PMID:30047161 | TTLL3 | Human | methylarsonic acid | multiple interactions | ISO | Ttll3 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL3 mRNA | CTD | PMID:34876320 | TTLL3 | Human | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Ttll3 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TTLL3 mRNA | CTD | PMID:36189433 | TTLL3 | Human | N-acetyl-beta-D-glucosamine | decreases expression | EXP | | 6480464 | Acetylglucosamine results in decreased expression of TTLL3 mRNA | CTD | PMID:18047607 | TTLL3 | Human | N-acetyl-D-glucosamine | decreases expression | EXP | | 6480464 | Acetylglucosamine results in decreased expression of TTLL3 mRNA | CTD | PMID:18047607 | TTLL3 | Human | N-methyl-4-phenylpyridinium | increases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of TTLL3 mRNA | CTD | PMID:28801915 | TTLL3 | Human | niclosamide | increases expression | EXP | | 6480464 | Niclosamide results in increased expression of TTLL3 mRNA | CTD | PMID:36318118 | TTLL3 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of TTLL3 mRNA | CTD | PMID:22230336 | TTLL3 | Human | paracetamol | increases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of TTLL3 mRNA | CTD | PMID:33387578 | TTLL3 | Human | perfluorohexanesulfonic acid | decreases expression | ISO | Ttll3 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of TTLL3 mRNA | CTD | PMID:37995155 | TTLL3 | Human | perfluorooctanoic acid | multiple interactions | ISO | Ttll3 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TTLL3 mRNA | CTD | PMID:35163327 | TTLL3 | Human | potassium dichromate | decreases expression | ISO | Ttll3 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of TTLL3 mRNA | CTD | PMID:23608068 | TTLL3 | Human | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of TTLL3 mRNA | CTD | PMID:21632981 | TTLL3 | Human | rotenone | affects expression | ISO | Ttll3 (Mus musculus) | 6480464 | Rotenone affects the expression of TTLL3 mRNA | CTD | PMID:21893155 | TTLL3 | Human | rotenone | multiple interactions | ISO | Ttll3 (Mus musculus) | 6480464 | TRP53 affects the reaction [Rotenone affects the expression of TTLL3 mRNA] | CTD | PMID:21893155 | TTLL3 | Human | silicon dioxide | increases expression | ISO | Ttll3 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of TTLL3 mRNA | CTD | PMID:19073995 | TTLL3 | Human | sodium arsenate | multiple interactions | ISO | Ttll3 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL3 mRNA | CTD | PMID:34876320 | TTLL3 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of TTLL3 mRNA | CTD | PMID:38568856 | TTLL3 | Human | sodium arsenite | multiple interactions | ISO | Ttll3 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL3 mRNA | CTD | PMID:34876320 | TTLL3 | Human | sulfadimethoxine | decreases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in decreased expression of TTLL3 mRNA | CTD | PMID:30047161 | TTLL3 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of TTLL3 mRNA | CTD | PMID:31533062 | TTLL3 | Human | theophylline | affects binding | EXP | | 6480464 | Theophylline binds to TTLL3 protein | CTD | PMID:18951874 | TTLL3 | Human | thioacetamide | decreases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of TTLL3 mRNA | CTD | PMID:34492290 | TTLL3 | Human | titanium dioxide | increases expression | ISO | Ttll3 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of TTLL3 mRNA | CTD | PMID:29264374 | TTLL3 | Human | trichloroethene | increases expression | ISO | Ttll3 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of TTLL3 mRNA | CTD | PMID:33387578 | TTLL3 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of TTLL3 mRNA | CTD | PMID:37042841 | TTLL3 | Human | triptonide | increases expression | ISO | Ttll3 (Mus musculus) | 6480464 | triptonide results in increased expression of TTLL3 mRNA | CTD | PMID:33045310 | TTLL3 | Human | trovafloxacin | increases expression | ISO | Ttll3 (Mus musculus) | 6480464 | trovafloxacin results in increased expression of TTLL3 mRNA | CTD | PMID:35537566 | |